Federal contract award

75N93019C00045

TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST NO FEE
Obligations$18.5M
Current contract value$18.5M
Potential contract value / ceiling$18.5M
Start dateSep 6, 2019
Current end dateSep 29, 2027
Potential end dateSep 29, 2027
Latest award activityJul 27, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 27 of 27 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 27, 2026P00026$0EO14398 VACCINE ADJ DISCOVERY PROGRAM (VADP)
Apr 21, 2025P00025$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Jan 14, 2025P00024$-0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Sep 11, 2024P00023$612.1KVACCINE ADJ DISCOVERY PROGRAM (VADP)
Sep 5, 2024P00022$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 6, 2024P00021$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Jun 29, 2023P00020$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
May 5, 2023P00019$2.2MVACCINE ADJ DISCOVERY PROGRAM (VADP)
Apr 4, 2023P00018$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Sep 7, 2022P00017$1.6MVACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 16, 2022P00016$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Jul 22, 2022P00015$2.1MVACCINE ADJ DISCOVERY PROGRAM (VADP)
Jun 6, 2022P00014$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Apr 7, 2022P00012$2.6MVACCINE ADJ DISCOVERY PROGRAM (VADP)
Apr 7, 2022P00013$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Oct 13, 2021P00011$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 31, 2021P00010$200.0KVACCINE ADJ DISCOVERY PROGRAM (VADP)
Jul 27, 2021P00009$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Jul 19, 2021P00008$2.3MVACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 27, 2020P00007$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 25, 2020P00006$0VACCINE ADJ DISCOVERY PROGRAM (VADP)
Aug 5, 2020P00005$1.2MEXPANDS THE ACTIVITIES WITH RESEARCH AREA 4
Jul 21, 2020P00004$1.7MVACCINE ADJUVANT
Apr 23, 2020P00003$2.5MCOVID-19
Dec 10, 2019P00002$0TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
Sep 16, 2019P00001$1.4MTO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
Sep 6, 20190$0TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.

Estimated positioning window

Nov 1, 2026 – Mar 29, 2027

Recompete signal:
80/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 80/100. Available recorded signals: 75 points.

Contract end 2027-09-29 (332 days from calculation)
+35 points
157 historical awards in this buyer and category group
+15 points
27 recorded award transactions
+10 points
Latest award action: 2026-07-27
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.